Alkem Laboratories informs about press release

04 Aug 2021 Evaluate

Alkem Laboratories has informed that the Company has launched Ibuprofen and Famotidine Tablets in the United States, following an approval from the United States Food and Drug Administration (US FDA). A press release in this regard is enclosed on 4th August 2021 titled ‘Alkem Launches Ibuprofen and Famotidine Tablets in the United States’.

The above information is a part of company’s filings submitted to BSE.


Alkem Laboratories Share Price

5765.40 107.60 (1.90%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×